Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07290842
Recruiting
The Effects of Dietary Nitrate in Patients With Hypertensive Kidney Injury
Not applicable · Denmark · 1 site
Registry update: 18 Dec 2025
NCT07340463
Recruiting
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Phase 2 · China · 1 site
Registry update: 12 Mar 2026
NCT07241520
Recruiting
Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke
Phase 3 · China · 1 site
Registry update: 6 Jan 2026
NCT07038356
Recruiting
Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure
Phase 3 · Germany · 14 sites
Registry update: 4 Nov 2026
NCT07616232
Recruiting
School and Family-Based Obesity Prevention in Pakistani Primary School Children
Not applicable · Pakistan · 1 site
Registry update: 2 Jun 2026
NCT05613972
Recruiting
Integrated Suicide & Trauma Therapy for Suicide Risk
Not applicable · Canada · 1 site
Registry update: 17 Aug 2026
NCT07324304
Recruiting
NWRD06 DNA Plasmid for HCC After Curative Resection.
Phase 2 · China · 6 sites
Registry update: 7 Jan 2026
NCT07322627
Recruiting
ALDH2 Single Nucleotide Polymorphisms and Prognosis of Esophageal Cancer Patients
Not applicable · Taiwan · 1 site
Registry update: 7 Jan 2026
NCT06992739
Recruiting
Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase 2 · China · 1 site
Registry update: 14 Apr 2026
NCT07097363
Recruiting
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
Phase 2 · United States · 1 site
Registry update: 21 Oct 2026
NCT07554820
Recruiting
Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL
Phase 4 · Pakistan · 1 site
Registry update: 28 Apr 2026
NCT07534033
Recruiting
Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer
Phase 2 · China · 1 site
Registry update: 29 Oct 2026
NCT07447089
Recruiting
EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study
Not applicable · Italy · 1 site
Registry update: 4 Mar 2026
NCT07235904
Recruiting
Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis
Phase 4 · Germany · 22 sites
Registry update: 16 Dec 2025
NCT07032389
Recruiting
A Polypill for Acute Coronary Syndrome
Phase 2 · United States · 4 sites
Registry update: 23 Sept 2026
NCT06962163
Recruiting
Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients
Not applicable · France · 1 site
Registry update: 12 Jan 2026
NCT07228611
Recruiting
Assessment and Comparison of Osteoporosis Risk Factors After Stroke
Not applicable · 1 site
Registry update: 2 Nov 2026
NCT07275840
Recruiting
A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMD
Phase 2 · China · 1 site
Registry update: 8 Jan 2026
NCT07240883
Recruiting
ENDO1000 - A UK-wide Endometriosis Research Project
Not applicable · United Kingdom · 1 site
Registry update: 24 Jun 2026
2025-521034-28-00
Recruiting
A Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
Phase 2 · Belgium, Germany, Denmark, Spain, France, Italy, Poland · 31 sites
Registry update: 14 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.